ClinicalTrials.gg
Drug

Diosmin clinical trials

Also written Daflon.

studies test it
23
open now
7
in phase 3
9
first study started
2011

How each study uses Diosmin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Diosmin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Diosmin
13
Vasculera
2

Brand

Daflon
5

Studies by the year they started

23 studies that test it; most in 2023 (5)

Studies that test Diosmin, by start year
YearStudies
20111
20122
20141
20152
20172
20201
20211
20223
20235
20243
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
4
Phase 3
9
Phase 4
5
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 16

Ain Shams University (4) · Tanta University (4) · Pirogov Russian National Research Medical University (2) · Primus Pharmaceuticals (2) · Ittefaq Hospital trust (1) · Taipei Medical University Shuang Ho Hospital (1) · Laboratorios Andromaco S.A. (1) · Fundação Educacional Serra dos Órgãos (1)

Often tested with

Tested in the same studies.

Hesperidin (4) · Cabergoline (1) · Rebamipide (1) · Silymarin (1) · Flavonoids (1) · Loratadine (1) · Tranexamic Acid (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test Diosmin.

Studies

Open first, then newest update. How each study uses Diosmin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 23

See all 23 studies that test Diosmin →

Given beside what is tested · 1 — Diosmin is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Diosmin

Codes

What other systems call Diosmin · ClinicalTrials.gg INT007375

  • MeSH (NLM) D004145DiosminConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7QM776WJ5NDIOSMINConfirmed FDA, NLM, Wikidata
  • RxNorm 3489Confirmed FDA, Wikidata
  • Wikidata Q2607865diosminConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C81663DiosminOne source FDA
  • DrugBank DB08995One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.